LumiraDx News

Company Name Stock Ticker Symbol Market Type
LumiraDx Ltd LMDX NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
-0.05 -3.88% 1.24 12:56:10
Open Price Low Price High Price Close Price Prev Close
1.26 1.22 1.35 1.29
more quote information »

Recent News

Date Time Source Heading
12/05/20227:15IHNWFeaturedElectromedical Technologies Announces Financial and Operational Highlights for the Three and Nine Months Ended September 30, 2022
11/14/202209:44PRNUSLumiraDx Continues Commercial Expansion of its Rapid..
11/14/202209:41PRNCALumiraDx Continues Commercial Expansion of its Rapid..
11/14/202202:58GLOBELumiraDx Continues Commercial Expansion of its Rapid..
11/13/202223:05TRMNLumiraDx (LMDX) Gets a Buy from BTIG
11/11/202207:35TRMNRaymond James Remains a Buy on LumiraDx (LMDX)
11/09/202207:00GLOBELumiraDx Reports Third Quarter 2022 Results
11/02/202207:23GLOBELumiraDx to Announce Third Quarter Financial Results and..
8/19/202208:40TRMNAnalysts Offer Insights on Healthcare Companies: Arcutis..
8/18/202207:00GLOBELumiraDx Reports Second Quarter 2022 Results
8/11/202208:00GLOBELumiraDx to Announce Second Quarter Financial Results and..
7/21/202208:36PRNUSLumiraDx Announces Pricing of Public Offering of Common..
7/19/202209:09PRNUSLumiraDx Announces Proposed Public Offering of Common Shares
6/23/202223:15TRMNAnalysts Offer Insights on Healthcare Companies: Precision..
6/09/202208:33PRNUSLumiraDx Achieves CE Mark for COVID-19 Antigen Test on..
6/08/202206:03PRNUSLumiraDx Receives CE Mark for Two Multiplex Tests: LumiraDx..
6/02/202206:35PRNUSLumiraDx Expands its Cardiovascular Testing Portfolio with..
5/26/202205:39PRNUSLumiraDx HbA1c Test Achieves CE Mark, Addresses Growing..
5/26/202205:30PRNUSLumiraDx HbA1c Test Achieves CE Mark, Addresses Growing..
5/20/202205:15PRNUSLumiraDx Receives WHO Emergency Use Listing for SARS-CoV-2..
5/19/202208:55PRNUSLumiraDx Five-Minute SARS-CoV-2 Ag Ultra Test Achieves CE..
5/12/202208:38TRMNRaymond James Thinks LumiraDx’s Stock is Going to Recover
5/11/202216:01PRNUSLumiraDx Reports First Quarter 2022 Results
4/29/202208:02PRNUSLumiraDx to Announce First Quarter Financial Results and..
3/28/202215:36SEEKLumiraDx at a post-IPO low on expiry of lockup period -..
3/10/202206:12SEEKLumiraDx Non-GAAP EPS of -$0.08, revenue of $118.25M misses..
3/10/202206:05PRNUSLumiraDx Reports Fourth Quarter and Full Year 2021 Results
3/03/202209:03PRNUSLumiraDx to Announce Fourth Quarter and Full Year 2021..
3/01/202208:13SEEKLumiraDx to raise $56.5M in convertible notes offering
3/01/202207:00PRNUSLumiraDx Announces Pricing of $56.5 Million Convertible..
2/21/202204:00PRNUSLumiraDx Receives UK MHRA Approval for SARS-CoV-2 RNA STAR..
2/14/202214:31EDGARAmended Statement of Ownership (sc 13g/a)
1/14/202206:29SEEKLumiraDx's COVID-19 antigen test detects Omicron variant
1/14/202206:18PRNUSLumiraDx Lab Analysis Confirms its COVID-19 Antigen Test..
1/11/202211:17SEEKLumiraDx sees FY21 revenue $422M, consensus $376.57M
1/11/202209:02PRNUSLumiraDx has Commenced Shipments in Europe for its COVID-19..
1/11/202206:33PRNUSLumiraDx CRP Test Achieves CE Marking
12/23/202106:24SEEKLumiraDx COVID-19 & Flu rapid antigen test secures CE..
12/23/202106:03PRNUSLumiraDx COVID-19 & Flu A/B Rapid Antigen Test Achieves CE..
12/15/202109:00SEEKLumiraDx partners with Audere for solution to use with..
12/15/202108:17PRNUSLumiraDx Fast Lab Solutions Partners with Audere for At-Home..